Results 171 to 180 of about 1,850,686 (245)

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

open access: yesMolecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li   +10 more
wiley   +1 more source

32. The Value of the Independent Program Training Pathway

open access: yesPlastic and Reconstructive Surgery, Global Open
Ariel E. Figueroa, MD   +4 more
doaj   +1 more source

IL-1 protects from fatal systemic candidiasis in mice by inhibiting oxidative phosphorylation and hypoxia. [PDF]

open access: yesNat Commun
Horn S   +9 more
europepmc   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

open access: yesMolecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff   +11 more
wiley   +1 more source

22. Enhancing The Accuracy Of Planned Surgery With Computer Controlled Osteotomies

open access: yesPlastic and Reconstructive Surgery, Global Open
Naji Bou Zeid, MD   +7 more
doaj   +1 more source

Pilot Study of IL-1 Antagonist Anakinra for Treatment of Endometriosis. [PDF]

open access: yesInt J Womens Health
Sullender RT   +5 more
europepmc   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

SO27. First Rib-Sparing Vs. Rib Resection in Thoracic Outlet Syndrome: Functional Outcomes in 105 Patients

open access: yesPlastic and Reconstructive Surgery, Global Open
Iulianna Taritsa, BA   +10 more
doaj   +1 more source

IL-1 modulation preserves biomolecular, structural and functional integrity of the somatosensory cortex after fetal inflammation

open access: yes
Galinsky R   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy